Ben Ghorbel I, Belfeki N, Baouendi N, Ben Salem T, Houman M H
Department of Internal Medicine, Medical Faculty of Tunis.
Reumatismo. 2017 May 22;69(1):23-29. doi: 10.4081/reumatismo.2017.935.
Granulomatosis with polyangiitis (GPA) is more frequent in Northern rather than Southern countries. Very few studies have been conducted in Africa. We have performed a retrospective descriptive study including clinical and laboratory profiles of 30 Tunisian GPA patients seen at the department of Internal Medicine of the University Hospital of la Rabta from 2000 to 2014. Mean age at initial GPA diagnosis was 46±12 years, and the average number of months between the onset of symptoms and diagnosis was 25. Seventeen (56%) were male, and 13 (44%) were female. Ear/nose/throat involvement occurred in 83%. Lung and renal involvement were observed in respectively 70% and 56% followed by mucocutaneous (50%), neurological (50%), ocular (33%), vascular (20%), ureteral (16%), and cardiac involvement in 10%. Cytoplasmic pattern-antineutrophil cytoplasmic antibodies (ANCA) was detected in 27 (90%) patients. Induction therapy consisted of intravenous cyclophosphamide pulses in 27 patients (90%) and oral methotrexate in 3 patients (10%). Trimethoprime-sulfamethoxazole was used in 26 patients (86%). Maintenance therapy consisted of azathioprine in 17 cases and methotrexate in 13 cases. Relapses occurred in 36%. Eighteen patients had favorable outcome and 12 died. Our patients had a distinct phenotype with high prevalence of pleural involvement, lymph node enlargement, sensorimotor neuropathy and ureter stenosis. ENT symptoms were less frequent as inaugural presentation. Overall 2-year survival was 60%.
肉芽肿性多血管炎(GPA)在北方国家比南方国家更为常见。在非洲进行的研究极少。我们开展了一项回顾性描述性研究,纳入了2000年至2014年在拉巴特大学医院内科就诊的30例突尼斯GPA患者的临床和实验室资料。GPA初次诊断时的平均年龄为46±12岁,症状出现至诊断的平均月数为25个月。17例(56%)为男性,13例(44%)为女性。83%的患者有耳鼻喉受累。肺和肾受累分别为70%和56%,其次是皮肤黏膜(50%)、神经(50%)、眼部(33%)、血管(20%)、输尿管(16%),心脏受累为10%。27例(90%)患者检测到胞浆型抗中性粒细胞胞浆抗体(ANCA)。诱导治疗中,27例(90%)患者采用静脉环磷酰胺脉冲治疗,3例(10%)患者采用口服甲氨蝶呤治疗。26例(86%)患者使用了复方新诺明。维持治疗中,17例采用硫唑嘌呤,13例采用甲氨蝶呤。36%的患者出现复发。18例患者预后良好,12例死亡。我们的患者具有独特的表型,胸膜受累、淋巴结肿大、感觉运动性神经病变和输尿管狭窄的发生率较高。耳鼻喉症状作为首发表现的情况较少见。总体2年生存率为60%。